Skip to main content
Top
Published in: Nuclear Medicine and Molecular Imaging 4/2014

01-12-2014 | Original Article

Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: A Preliminary Result

Authors: Seunggyun Ha, Hongyoon Choi, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, Euishin Edmund Kim, Dong Soo Lee

Published in: Nuclear Medicine and Molecular Imaging | Issue 4/2014

Login to get access

Abstract

Purpose

Texture analysis on 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) scan is a relatively new imaging analysis tool to evaluate metabolic heterogeneity. We analyzed the difference in textural characteristics between non-small cell lung carcinoma (NSCLC) subtypes, namely adenocarcinoma (ADC) and squamous cell carcinoma (SqCC).

Methods

Diagnostic 18F-FDG PET/computed tomography (CT) scans of 30y patients (median age, 67; range, 42-88) with NSCLC (17 ADC and 13 SqCC) were retrospectively analyzed. Regions of interest were manually determined on selected transverse image containing the highest SUV value in tumors. Texture parameters were extracted by histogram-based algorithms, absolute gradient-based algorithms, run-length matrix-based algorithms, co-occurrence matrix-based algorithms, and autoregressive model-based algorithms. Twenty-four out of hundreds of texture features were selected by three algorithms: Fisher coefficient, minimization of both classification error probability and average correlation, and mutual information. Automated clustering of tumors was based on the most discriminating feature calculated by linear discriminant analysis (LDA). Each tumor subtype was determined by histopathologic examination after biopsy and surgery.

Results

Fifteen texture features had significant different values between ADC and SqCC. LDA with 24 automate-selected texture features accurately clustered between ADC and SqCC with 0.90 linear separability. There was no high correlation between SUVmax and texture parameters (|r| ≤ 0.62).

Conclusion

Each subtype of NSCLC tumor has different metabolic heterogeneity. The results of this study support the potential of textural parameters on FDG PET as an imaging biomarker.
Literature
1.
go back to reference Jung K-W, Park S, Kong H-J, Won Y-J, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012;44(1):11–24.PubMedCentralPubMedCrossRef Jung K-W, Park S, Kong H-J, Won Y-J, Lee JY, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat. 2012;44(1):11–24.PubMedCentralPubMedCrossRef
2.
go back to reference Podbielski FJ, Rodriguez HE, Brown AM, Blecha MJ, Salazar MR, Connolly MM. Percutaneous biopsy in evaluation of lung nodules. JSLS. 2004;8(3):213–6.PubMedCentralPubMed Podbielski FJ, Rodriguez HE, Brown AM, Blecha MJ, Salazar MR, Connolly MM. Percutaneous biopsy in evaluation of lung nodules. JSLS. 2004;8(3):213–6.PubMedCentralPubMed
3.
go back to reference Han B, Lin S, Yu L-J, Wang R-Z, Wang Y-Y. Correlation of 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer. Nucl Med Commun. 2009;30(11):831–7.PubMedCrossRef Han B, Lin S, Yu L-J, Wang R-Z, Wang Y-Y. Correlation of 18F-FDG PET activity with expressions of survivin, Ki67, and CD34 in non-small-cell lung cancer. Nucl Med Commun. 2009;30(11):831–7.PubMedCrossRef
4.
go back to reference Rahim MK, Kim SE, So H, Kim HJ, Cheon GJ, Lee ES, et al. Recent trends in PET image interpretations using volumetric and texture-based quantification methods in nuclear oncology. Nucl Med Mol Imaging. 2014:1-15. Rahim MK, Kim SE, So H, Kim HJ, Cheon GJ, Lee ES, et al. Recent trends in PET image interpretations using volumetric and texture-based quantification methods in nuclear oncology. Nucl Med Mol Imaging. 2014:1-15.
5.
go back to reference Budiawan H, Cheon GJ, Im H-J, Lee SJ, Paeng JC, Kang KW, et al. Heterogeneity analysis of 18F-FDG uptake in differentiating between metastatic and inflammatory lymph nodes in adenocarcinoma of the lung: comparison with other parameters and its application in a clinical setting. Nucl Med Mol Imaging. 2013;47(4):232–41.PubMedCrossRef Budiawan H, Cheon GJ, Im H-J, Lee SJ, Paeng JC, Kang KW, et al. Heterogeneity analysis of 18F-FDG uptake in differentiating between metastatic and inflammatory lymph nodes in adenocarcinoma of the lung: comparison with other parameters and its application in a clinical setting. Nucl Med Mol Imaging. 2013;47(4):232–41.PubMedCrossRef
6.
go back to reference Castellano G, Bonilha L, Li LM, Cendes F. Texture analysis of medical images. Clin Radiol. 2004;59(12):1061–9.PubMedCrossRef Castellano G, Bonilha L, Li LM, Cendes F. Texture analysis of medical images. Clin Radiol. 2004;59(12):1061–9.PubMedCrossRef
7.
go back to reference Collewet G, Strzelecki M, Mariette F. Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging. 2004;22(1):81–91.PubMedCrossRef Collewet G, Strzelecki M, Mariette F. Influence of MRI acquisition protocols and image intensity normalization methods on texture classification. Magn Reson Imaging. 2004;22(1):81–91.PubMedCrossRef
9.
go back to reference Balakrishnama S, Ganapathiraju A. Linear discriminant analysis—a brief tutorial. Institute for Signal and information Processing, Mississippi State University, Starkville. 1998. Balakrishnama S, Ganapathiraju A. Linear discriminant analysis—a brief tutorial. Institute for Signal and information Processing, Mississippi State University, Starkville. 1998.
10.
go back to reference Saif MW, Tzannou I, Makrilia N, Syrigos K. Role and cost effectiveness of PET/CT in management of patients with cancer. Yale J Biol Med. 2010;83(2):53.PubMedCentralPubMed Saif MW, Tzannou I, Makrilia N, Syrigos K. Role and cost effectiveness of PET/CT in management of patients with cancer. Yale J Biol Med. 2010;83(2):53.PubMedCentralPubMed
11.
go back to reference Choi ES, Ha SG, Kim HS, Ha JH, Paeng JC, Han I. Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma. Eur J Nucl Med Mol Imaging. 2013;40(12):1836–42.PubMedCrossRef Choi ES, Ha SG, Kim HS, Ha JH, Paeng JC, Han I. Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma. Eur J Nucl Med Mol Imaging. 2013;40(12):1836–42.PubMedCrossRef
12.
go back to reference Im H-J, Kim YK, Kim Y-i, Lee JJ, Lee WW, Kim SE. Usefulness of combined metabolic–volumetric indices of 18F-FDG PET/CT for the early prediction of neoadjuvant chemotherapy outcomes in breast cancer. Nucl Med and Mole Imaging. 2013:1-8. Im H-J, Kim YK, Kim Y-i, Lee JJ, Lee WW, Kim SE. Usefulness of combined metabolic–volumetric indices of 18F-FDG PET/CT for the early prediction of neoadjuvant chemotherapy outcomes in breast cancer. Nucl Med and Mole Imaging. 2013:1-8.
13.
go back to reference Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-le RC. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011;38(7):1191–202.PubMedCrossRef Hatt M, Visvikis D, Albarghach NM, Tixier F, Pradier O, Cheze-le RC. Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011;38(7):1191–202.PubMedCrossRef
14.
go back to reference Holli K, Laaperi AL, Harrison L, Luukkaala T, Toivonen T, Ryymin P, et al. Characterization of breast cancer types by texture analysis of magnetic resonance images. Acad Radiol. 2010;17(2):135–41.PubMedCrossRef Holli K, Laaperi AL, Harrison L, Luukkaala T, Toivonen T, Ryymin P, et al. Characterization of breast cancer types by texture analysis of magnetic resonance images. Acad Radiol. 2010;17(2):135–41.PubMedCrossRef
15.
go back to reference Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573–89.PubMedCentralPubMedCrossRef Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573–89.PubMedCentralPubMedCrossRef
16.
go back to reference Ba-Ssalamah A, Muin D, Schernthaner R, Kulinna-Cosentini C, Bastati N, Stift J, et al. Texture-based classification of different gastric tumors at contrast-enhanced CT. Eur J Radiol. 2013;82(10):e537–43.PubMedCrossRef Ba-Ssalamah A, Muin D, Schernthaner R, Kulinna-Cosentini C, Bastati N, Stift J, et al. Texture-based classification of different gastric tumors at contrast-enhanced CT. Eur J Radiol. 2013;82(10):e537–43.PubMedCrossRef
17.
go back to reference Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, Roy A, et al. Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med. 2013;54(1):19–26.PubMedCrossRef Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, Roy A, et al. Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med. 2013;54(1):19–26.PubMedCrossRef
18.
go back to reference Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380–8.PubMedCrossRef Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010;362(25):2380–8.PubMedCrossRef
19.
go back to reference Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, et al. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol. 2008;3(9):971–8.PubMedCrossRef Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, et al. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol. 2008;3(9):971–8.PubMedCrossRef
20.
go back to reference Choi H, Paeng JC, Kim D-W, Lee JK, Park CM, Kang KW, et al. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT. Lung Cancer. 2012;79(3):242-7. Choi H, Paeng JC, Kim D-W, Lee JK, Park CM, Kang KW, et al. Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT. Lung Cancer. 2012;79(3):242-7.
21.
go back to reference Putora PM, Fruh M, Muller J. FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology. 2013;18(4):734–5.PubMedCrossRef Putora PM, Fruh M, Muller J. FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology. 2013;18(4):734–5.PubMedCrossRef
22.
go back to reference Cheng NM, Fang YH, Yen TC. The promise and limits of PET texture analysis. Ann Nucl Med. 2013;27(9):867–9.PubMedCrossRef Cheng NM, Fang YH, Yen TC. The promise and limits of PET texture analysis. Ann Nucl Med. 2013;27(9):867–9.PubMedCrossRef
23.
go back to reference Wu H, Sun T, Wang J, Li X, Wang W, Huo D, et al. Combination of radiological and gray level co-occurrence matrix textural features used to distinguish solitary pulmonary nodules by computed tomography. J Digit Imaging. 2013;26(4):797–802.PubMedCentralPubMedCrossRef Wu H, Sun T, Wang J, Li X, Wang W, Huo D, et al. Combination of radiological and gray level co-occurrence matrix textural features used to distinguish solitary pulmonary nodules by computed tomography. J Digit Imaging. 2013;26(4):797–802.PubMedCentralPubMedCrossRef
24.
go back to reference Chicklore S, Goh V, Siddique M, Roy A, Marsden PK, Cook GJ. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging. 2013;40(1):133–40.PubMedCrossRef Chicklore S, Goh V, Siddique M, Roy A, Marsden PK, Cook GJ. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging. 2013;40(1):133–40.PubMedCrossRef
25.
go back to reference Ye J, Janardan R, Li Q. Two-dimensional linear discriminant analysis. In: Advances in neural information processing systems. San Mateo: Morgan Kaufmann Publishers; 2004. Ye J, Janardan R, Li Q. Two-dimensional linear discriminant analysis. In: Advances in neural information processing systems. San Mateo: Morgan Kaufmann Publishers; 2004.
26.
go back to reference Larson SM. Cancer or inflammation? A holy grail for nuclear medicine. J Nucl Med. 1994;35(10):1653–5.PubMed Larson SM. Cancer or inflammation? A holy grail for nuclear medicine. J Nucl Med. 1994;35(10):1653–5.PubMed
27.
go back to reference Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44(9):1426–31.PubMed Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44(9):1426–31.PubMed
28.
go back to reference Galavis PE, Hollensen C, Jallow N, Paliwal B, Jeraj R. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters. Acta Oncol. 2010;49(7):1012–6.PubMedCentralPubMedCrossRef Galavis PE, Hollensen C, Jallow N, Paliwal B, Jeraj R. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters. Acta Oncol. 2010;49(7):1012–6.PubMedCentralPubMedCrossRef
Metadata
Title
Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: A Preliminary Result
Authors
Seunggyun Ha
Hongyoon Choi
Gi Jeong Cheon
Keon Wook Kang
June-Key Chung
Euishin Edmund Kim
Dong Soo Lee
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Nuclear Medicine and Molecular Imaging / Issue 4/2014
Print ISSN: 1869-3474
Electronic ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-014-0283-3

Other articles of this Issue 4/2014

Nuclear Medicine and Molecular Imaging 4/2014 Go to the issue